Cognex Corporation — Q1 2015 Form 10-Q
Reporting period: Three months ended April 5, 2015; comparisons are with the three months ended March 30, 2014. Cognex supplies machine-vision systems and services through its Modular Vision Systems Division (MVSD) and Surface Inspection Systems Division (SISD), serving factory automation, semiconductor/electronics equipment, and surface inspection markets.
Financial highlights
| Metric | Q1 2015 | Q1 2014 | Change |
|---|---|---|---|
| Revenue | $113.4 million | $90.9 million | +25% |
| Gross margin | $85.5 million; 75% of revenue | $69.8 million; 77% | Margin down 2 percentage points |
| Operating income | $23.9 million; 21% of revenue | $22.4 million; 25% | +7% |
| Net income | $20.5 million | $18.5 million | +11% |
| Diluted EPS | $0.23 | $0.21 | +$0.02 |
| Operating cash flow | $(0.3) million | $17.5 million | Down $17.7 million |
| Cash, equivalents and investments | $548.8 million | $547.0 million at Dec. 31, 2014 | Up $1.8 million |
At April 5, 2015, current assets were $310.0 million and current liabilities $66.9 million. The company reported no debt. Cash and cash equivalents were $36.0 million; short- and long-term investments totaled $512.8 million. Capital expenditures were $4.3 million. Cash declined $19.6 million during the quarter, while investment purchases exceeded maturities and sales by $26.6 million.
Performance changes and management commentary
- Growth was led by factory automation, representing 84% of revenue. Factory automation sales rose 26% reported and 34% at constant currency, driven in part by large consumer-electronics orders. Management expected this market’s revenue to increase again in Q2 versus Q1.
- Semiconductor/electronics equipment revenue increased 5% year over year; management noted the market’s cyclicality and limited visibility into future orders. Surface inspection revenue rose 25% year over year, but fell 35% sequentially from a record Q4; quarterly results can vary with orders, deliveries, installations, and revenue deferrals.
- Operating expenses rose 30% to $61.6 million, mainly from additional personnel, compensation, and other growth-related investment. R&D increased 45%; R&D was 16% of revenue, and management said it targets spending of 10%–15% of revenue while expecting significant continued investment.
- Gross margin declined primarily because of volume discounts on large orders, new-product costs, and a mix shift toward lower-margin services. Management also cited material savings, purchasing scale, and manufacturing efficiencies as offsets.
- Net income included a lower effective tax rate of 18%, versus 19% a year earlier; a $364,000 discrete tax benefit reduced the 2015 rate. Foreign-currency translation reduced other comprehensive income by $10.7 million.
Liquidity, outlook, risks, and unusual items
- Management said existing cash, cash equivalents and investments, together with operating cash flow, should meet operating, investing, and financing needs for the next 12 months; it did not anticipate needing debt financing. The company had a remaining $614,000 commitment to its Venrock investment fund, callable through December 31, 2015.
- The board declared a $0.07-per-share dividend on May 4, payable June 19, 2015. No shares were repurchased during the quarter; $42.4 million remained under the $50 million repurchase authorization.
- Microscan litigation is a significant contingency. Cognex had previously received a $2.6 million jury award in its patent case, which Microscan appealed. In a separate case, a jury on April 30, after quarter-end, awarded Microscan $4.411 million in royalties related to Cognex product sales. Cognex said it intended to appeal, subject to the court’s final assessment; the filing says an adverse resolution could materially affect financial position, liquidity, results, or indemnification obligations. The filing text does not clearly state whether this post-quarter-end award was accrued in the reported quarter.
- Other disclosed risks include customer concentration, global economic and industry cyclicality, foreign-exchange movements, supplier dependence, product quality and transitions, competition, technology and intellectual-property risks, litigation, taxes, and information-security or system disruptions. Management reported no material change in market-risk exposures and concluded disclosure controls were effective.
- No comprehensive revenue or earnings forecast was provided. Management’s stated near-term outlook was growth in factory-automation revenue in Q2 versus Q1; it also emphasized limited visibility in semiconductor/electronics equipment demand.
Investor verification priorities
- Assess whether Q1 growth, especially the large consumer-electronics orders, is repeatable and how customer, industry, and geographic concentration may affect results.
- Track margin recovery against pricing discounts, product/service mix, new-product costs, and continued hiring and R&D investment.
- Reconcile the negative operating cash flow with earnings and monitor inventory growth and working-capital cash needs.
- Follow the Microscan appeals and any final judgment, payment, or financial-statement accrual related to the $4.411 million post-quarter verdict.
- Monitor foreign-exchange effects, investment portfolio liquidity and risk, the remaining Venrock commitment, and subsequent capital returns.